Home » Topics » Deals and M&A » Collaboration

Collaboration
RSS

Cortex Pharma regains rights to Ampakine agents for depression and schizophrenia

Oct. 5, 2010

Argenta and Janssen enter into cancer drug discovery agreement

Oct. 5, 2010

Eisai and Anaeropharma partner to discover Bifidobacterium-delivered anticancer agents

Oct. 5, 2010

Global marketing rights to Caelyx to transition from Merck & Co. to Janssen

Oct. 5, 2010

Dyax and CMIC partner in development and marketing of DX-88 for HAE in Japan

Oct. 4, 2010

Aveo Pharmaceuticals regains worldwide rights to AV-299

Oct. 4, 2010

Pieris, sanofi-aventis and Sanofi Pasteur to develop anticalin therapeutics

Oct. 1, 2010

Astellas and UMN Pharma enter definitive agreement for flu vaccines

Oct. 1, 2010

Dana-Farber Cancer Institute and sanofi-aventis collaborate on oncology targets

Sep. 30, 2010

RXi and EyeGate Pharma collaborate on ocular drug delivery system

Sep. 27, 2010

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...